Charles Reinhart
Director of Finance/CFO at PACIRA BIOSCIENCES, INC.
Net worth: 2 M $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kristen Williams | F | 50 | 13 years | |
| Paul Hastings | M | 64 | 13 years | |
| David Curiel | M | - |
Vectorlogics, Inc.
 Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | 26 years |
| Frank Lee | M | 56 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Marcelo Bigal | M | 54 | 1 years | |
| Michael Yang | M | 62 | 1 years | |
| Anthony Molloy | M | 50 | - | |
| Mark Froimson | M | 63 | 7 years | |
| Abraham Ceesay | M | 46 | 1 years | |
| Gary Pace | M | 76 | 16 years | |
| Alethia Young | F | 45 | 1 years | |
| Lauren Riker | F | 45 | 12 years | |
| Daryl Gaugler | M | 62 | 5 years | |
| Mark Kronenfeld | M | 69 | 11 years | |
| Laura Brege | F | 66 | 13 years | |
| Andreas Wicki | M | 64 | 18 years | |
| Christopher Christie | M | 61 | 5 years | |
| Jonathan Slonin | M | 49 | 3 years | |
| Robert W. Holthausen | M | 76 |
The Wharton School of the University of Pennsylvania
| 35 years |
| Jeffrey Levin | M | - | 6 years | |
| Christopher C. Young | M | 52 | 1 years | |
| Susan Mesco | F | - | 9 years | |
| J. David Sakura | M | - |
Vectorlogics, Inc.
Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | - |
| Sara Ghazaii Marino | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Stack | M | 72 | 17 years | |
| Philip MacNeill | M | 70 |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | - |
| Dennis L. Winger | M | 77 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 14 years |
| Jason Keefer | M | 52 | 5 years | |
| Kevin E. Moley | M | 77 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 7 years |
| Mitchel Sayare | M | 76 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | - |
| Scott Schaffner | M | 54 | - | |
| Joel Rogers | M | 62 | 2 years | |
| John Dawson | M | 64 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 11 years |
| Lawrence Berger | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Lee Jeffrey Tawil | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Gene Vivino | M | - |
The Wharton School of the University of Pennsylvania
Lehigh University
| 6 years |
| Richard Scranton | M | 57 | 9 years | |
| Mark Walters | M | 69 | 5 years | |
| Adam Blackman | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Eric Siegel | M | 60 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 3 years |
| Uwe Sommer | M | - | 1 years | |
| Yvonne Greenstreet | M | 61 | 9 years | |
| Roy Winston | M | 63 | - | |
| Max Reinhardt | M | 53 | - | |
| Vladimir Kharitonov | M | - | 13 years | |
| Farid Harianto | M | 68 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Michael Williams | M | - |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | - |
| Bryan Reasons | M | 56 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 6 years |
| Mike Sutter | M | - |
Lehigh University
| 9 years |
| Michael Zagger | M | - | - | |
| Samson Tom | M | 51 | 1 years | |
| Willi Miesch | M | 60 | 1 years | |
| Hyo Sang Lee | M | - |
Lehigh University
| 5 years |
| Peter A. Friedli | M | 70 | 27 years | |
| Jamie Kramer | F | - |
The Wharton School of the University of Pennsylvania
| 12 years |
| Alex Panos | M | - |
The Wharton School of the University of Pennsylvania
| 9 years |
| Patrick Enright | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Charles Homcy | M | 75 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 6 years |
| Anthony Clarke | M | 68 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 4 years |
| Jeffrey Runge | M | 67 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | - |
| Timothy Wilmott | M | 66 |
Lehigh University
| 5 years |
| Richard Sol Nackenson | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Scott Braunstein | M | 60 | 3 years | |
| Vaughn M. Kailian | M | 79 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | - |
| Andrew Pearson | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Thomas Knapp | M | 71 | 2 years | |
| James Scibetta | M | 59 | 9 years | |
| Louis A. Toth | M | - |
The Wharton School of the University of Pennsylvania
| 10 years |
| Luke Evnin | M | 60 | 7 years | |
| Julie Shimer | M | 71 |
Lehigh University
| 4 years |
| Glenn Fuhrman | M | 58 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Robert Foley | M | 64 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Alan L. Leonard Felder | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Elizabeth Levy-Navarro | F | 61 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Kristy Cunningham | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Carman Wong | F | 51 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Mitchell Resnick | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Maria Alejandra Herrera | F | 59 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Joseph P. Puglise | M | 53 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jonathan Huberman | M | 58 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Lilian Díaz-Bento | F | 57 |
The Wharton School of the University of Pennsylvania
| 4 years |
| John Stavig | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Stewart Kantor | M | 62 |
The Wharton School of the University of Pennsylvania
| 2 years |
| David J. Parker | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Neil Malik | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
| Carr T. Preston | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Carson Biederman | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Geraldo Travaglia Filho | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Keval Patel | M | - |
The Wharton School of the University of Pennsylvania
| 13 years |
| Matthew I. Roslin | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Christophe Charlier | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| William L. Potter | M | - |
The Wharton School of the University of Pennsylvania
| 1 years |
| Stephen Gordon | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Suresh Shanmugham | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Andrew Swinand | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Kurt Ekert | M | 53 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Larry Spyros Antonatos | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Mark Smith | M | 72 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Lawrence Robbins | M | 54 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Randall Bort | M | 60 |
The Wharton School of the University of Pennsylvania
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
| United Kingdom | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Charles Reinhart
- Personal Network
